Insider Trading History of Miller Richard A Md

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Miller Richard A Md since 2007. This trader's CIK number is 1031847. At the time of last reporting, Miller Richard A Md was the President and CEO of Corvus Pharmaceuticals, Inc.. (stock ticker symbol CRVS). Also see all insider trading activities at Corvus Pharmaceuticals, Inc..

Note that in the past MILLER RICHARD A MD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmacyclics Inc (PCYC) by Miller Richard A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 PCYC 10,000 $20,005 0 $0 0 $0

Yearly summary of insider trading at Corvus Pharmaceuticals, Inc. (CRVS) by Miller Richard A Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CRVS 0 $0 0 $0 559,073 $1,956,755
2024 CRVS 577,634 $999,884 0 $0 0 $0
2022 CRVS 105,890 $120,422 0 $0 0 $0
2021 CRVS 145,714 $469,249 0 $0 0 $0
2019 CRVS 49,720 $165,661 0 $0 0 $0
2018 CRVS 136,502 $998,700 0 $0 0 $0
2017 CRVS 35,000 $354,897 0 $0 0 $0


Insider trading activities at 2 companies by Miller Richard A Md:

1. Pharmacyclics Inc (PCYC)

2. Corvus Pharmaceuticals, Inc. (CRVS)

Table 1. Insider trading of Pharmacyclics Inc (PCYC) by Miller Richard A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-08-21 PCYC Buy 5,000 2.00 10,005
2007-08-22 PCYC Buy 5,000 2.00 10,000

Table 2. Insider trading of Corvus Pharmaceuticals, Inc. (CRVS) by Miller Richard A Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-07 CRVS Option Ex 559,073 3.50 1,956,755
2024-05-06 CRVS Buy 577,634 1.73 999,884
2022-09-28 CRVS Buy 25,000 .76 19,075
2022-09-20 CRVS Buy 20,000 .81 16,299
2022-06-24 CRVS Buy 5,000 1.03 5,150
2022-06-27 CRVS Buy 5,000 1.00 4,985
2022-06-06 CRVS Buy 890 1.01 898
2022-06-02 CRVS Buy 5,000 .97 4,875
2022-03-31 CRVS Buy 15,000 1.64 24,540
2022-03-15 CRVS Buy 25,000 1.47 36,650
2022-03-17 CRVS Buy 5,000 1.59 7,950
2021-08-20 CRVS Buy 10,000 1.93 19,250
2021-05-04 CRVS Buy 35,714 2.80 99,999
2021-02-17 CRVS Buy 100,000 3.50 350,000
2019-11-12 CRVS Buy 272 2.90 788
2019-11-13 CRVS Buy 14,736 3.00 44,237
2019-08-06 CRVS Buy 5,000 3.58 17,875
2019-08-07 CRVS Buy 2,500 3.54 8,850
2019-06-13 CRVS Buy 343 3.52 1,207
2019-06-14 CRVS Buy 11,657 3.40 39,668
2019-06-07 CRVS Buy 9,212 3.37 31,016
2019-06-11 CRVS Buy 6,000 3.67 22,020
2018-12-27 CRVS Buy 20,000 3.29 65,880
2018-12-20 CRVS Buy 10,000 4.39 43,949
2018-12-06 CRVS Buy 5,000 5.99 29,935
2018-12-04 CRVS Buy 1,502 5.95 8,936
2018-03-12 CRVS Buy 100,000 8.50 850,000
2017-11-20 CRVS Buy 10,000 10.79 107,850
2017-06-09 CRVS Buy 8,784 9.92 87,137
2017-06-12 CRVS Buy 11,216 9.82 110,185
2017-06-13 CRVS Buy 5,000 9.95 49,725

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Miller Richard A Md (President and CEO of Corvus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.